| Description |
The Company was incorporated in Singapore on 29 September 2003 under the name
of Sinopharm Pte Ltd and it changed its name to Pharmesis International Pte Ltd
on 16 April 2004. It adopted its current name on 30 August 2004.
Pharmesis specializes in the manufacture of pharmaceutical products, including
western medicine and Traditional Chinese Medicine (“TCM’’).
Under its two subsidiaries, Kinna Pharm and Longlife, it specializes in the
manufacturing of pharmaceutical products in the form of tablets, granules,
pills, etc, including TCM formulated products for the treatment of illnesses
relating to the liver and gall bladder. Its two main products are ATT tablets
and Gansu granules. Additionally, its business also includes the research and
development, production, sale and marketing of pharmaceutical products. These
pharmaceutical products are sold in China and they include western medicine
products under the “?? ” brand, while its TCM formulated products are sold
under the “???? ” brand.
Leveraging its research and development capabilities and in-house expertise in
pharmaceutical products for the treatment of illnesses relating to the liver
and gall bladder, Pharmesis has successfully obtained the license to produce
ATT tablets in China. Similarly, it is the only Group with the right to produce
Gansu granules from Ganhuangcao in China.
With sales and marketing network of approximately 900 sales personnel across
China, its products can be found in 2,000 hospitals in many cities within
China.
The Groups two production facilities are located in Chengdu and Gulin, China.
Additional info from SGX:
The Company was incorporated in Singapore on 29 September 2003 under the name
of Sinopharm Pte Ltd and it changed its name to Pharmesis International Pte Ltd
on 16 April 2004. It adopted its current name on 30 August 2004.
Pharmesis specializes in the manufacture of pharmaceutical products, including
western medicine and Traditional Chinese Medicine (“TCM’’).
Under its two subsidiaries, Kinna Pharm and Longlife, it specializes in the
manufacturing of pharmaceutical products in the form of tablets, granules,
pills, etc, including TCM formulated products for the treatment of illnesses
relating to the liver and gall bladder. Its two main products are ATT tablets
and Gansu granules. Additionally, its business also includes the research and
development, production, sale and marketing of pharmaceutical products. These
pharmaceutical products are sold in China and they include western medicine
products under the “?? ” brand, while its TCM formulated products are sold
under the “???? ” brand.
Leveraging its research and development capabilities and in-house expertise in
pharmaceutical products for the treatment of illnesses relating to the liver
and gall bladder, Pharmesis has successfully obtained the license to produce
ATT tablets in China. Similarly, it is the only Group with the right to produce
Gansu granules from Ganhuangcao in China.
With sales and marketing network of approximately 900 sales personnel across
China, its products can be found in 2,000 hospitals in many cities within
China.
The Groups two production facilities are located in Chengdu and Gulin, China.
|
|---|